Diasorin in the news
WebThe new paradigm in EARLY Lyme borreliosis detectionDiaSorin strives to improve health-care around the globe through the development of innovative diagnostic solutions that can lead to better patient outcomes and provide economic benefits to the healthcare system. Thanks to its team of dedicated scientists, DiaSorin has developed a new concept … WebJan 24, 2024 · Diasorin and Policlinico San Matteo declined to comment on the trial, news of which sent the company’s Milan-listed shares to close 5.7% lower.
Diasorin in the news
Did you know?
WebApr 12, 2024 · Business category DiaSorin dips over 9%, brokers cite cut to underlying sales growth outlook. ... Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news ... WebMar 20, 2024 · NEW YORK – DiaSorin said late Friday that it has nabbed US Food and Drug Administration 510(k) clearance for a molecular assay that differentiates between infections with the SARS-CoV-2 and influenza A and B viruses. The Saluggia, Italy-based firm said it received the green light from the agency for its multiplex Simplexa COVID-19 …
Web7 hours ago · Previsioni del prezzo azioni Ferrari (RACE) Il prezzo attuale delle azioni Ferrari è €256,50, in guadagno del +2,74% ad un mese e in rialzo del 35,06% a 6 mesi, … Per the deal, Luminex will get merged with DiaSorin’s newly formed U.S. subsidiary, with the former’s shareholders receiving $37 in cash for each of their shares. It is worth mentioning that the transaction will be funded through a mix of cash and external financing. Notably, the buyout is anticipated to … See more The transaction will enable Luminex to enhance the value received by its customers via an expanded global product and service portfolio. … See more Last month, Luminex submitted an Emergency Use Authorization application (EUA) to the FDA for the company's new multi-analyte … See more Per a report published on Grand View Research, the global molecular diagnostics market was valued at $9.2 billion in 2024 and is expected to reach $18.2 billion by 2027, witnessing a CAGR of 9% between 2024 … See more Shares of the Zacks Rank #3 (Hold) company have gained 60.1% on a year-to-date basis, against the industry’s decline of 1.7%. See more
WebApr 15, 2024 · Diasorin, The Diagnostic Specialist. We are global leader in the laboratory diagnostics market, specializing in the immunodiagnostics and molecular diagnostics segments. For over 50 years our Group has …
WebApr 11, 2024 · April 11, 2024 - DiaSorin S.p.A. today announced that its Board of Directors has unanimously approved and signed a definitive merger agreement for DiaSorin to acquire Luminex Corporation for a price... February 6, 2024 ... DiaSorin will host a new Investor Day by the end of September 2024. Estimated as combined Net Financial …
WebDiaSorin is an Italian multinational biotechnology company that produces and markets in vitro diagnostics reagent kits used in immunodiagnostics and molecular diagnostics and … dat7 whyWebMar 20, 2024 · (Alliance News) - DiaSorin Spa announced Friday that it has received clearance from the U.S. Food and Drug Administration for the Simplexa Covid-19 & Flu A/B Direct test. The test detects and differentiates influenza type A and B and SARS-CoV-2 viruses, providing physicians with the information they need to determine the most … bitflow solutionsWebDiaSorin Molecular diagnostic products assist labs in consolidation of in house and send out testing to improve efficiency. ... DiaSorin Molecular CE Marks their new Simplexa™ COVID-19 & Flu A/B Direct Assay for Detection and Differentiation of SARS-CoV-2 and Influenza in One Test. bitflx.itWebApr 12, 2024 · If you'd like to view a copy of the company's affirmative action plan or policy statement, please email: [email protected]. If you have a disability and you believe you need a reasonable accommodation in order to search for a job opening or to submit an online application, please e-mail: [email protected] or call toll-free 1.800.328.1482. bitflow wolmaransstadWebOct 5, 2024 · D IA S ORIN FURTHERS ITS COLLABORATIONS WITH BARDA TO SUPPORT CLINICAL VALIDATION AND FDA 510 ( K) CLEARANCE OF THE LIAISON® NES SYSTEM, A POC. Saluggia, Italy, October 5, 2024 - DiaSorin (FTSE MIB: DIA) announced today that DiaSorin Molecular LLC (Cypress, CA) will collaborate with the … bitflow technologyWebSARS-CoV-2 Testing Methods. Description: Since the declaration of the COVID-19 pandemic in March 2024, there have been strong efforts by laboratories and industry to … dat 30days free trailWebAt DiaSorin you won’t just be an intern; you will be a key member of the DiaSorin team. You can expect to be tasked with exciting project(s) working with cross functional team members that capitalize on your existing skills and challenge you in new growth areas. The variety of business-critical projects means that no two roles will be alike ... bitfly cloud